Business Description
EZZ Life Science Holdings Ltd
ISIN : AU0000130569
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 41.51 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.06 | |||||
Interest Coverage | 197.95 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 11.85 | |||||
Beneish M-Score | -2.62 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Book Growth Rate | 22.2 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 54.42 | |||||
9-Day RSI | 59.29 | |||||
14-Day RSI | 63.95 | |||||
6-1 Month Momentum % | 12.07 | |||||
12-1 Month Momentum % | 22.64 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.92 | |||||
Quick Ratio | 3.61 | |||||
Cash Ratio | 2.52 | |||||
Days Inventory | 34.6 | |||||
Days Sales Outstanding | 21.78 | |||||
Days Payable | 94.12 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.3 | |||||
Dividend Payout Ratio | 0.24 | |||||
Forward Dividend Yield % | 2.83 | |||||
5-Year Yield-on-Cost % | 2.48 | |||||
3-Year Average Share Buyback Ratio | -0.6 | |||||
Shareholder Yield % | 1.37 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 74.77 | |||||
Operating Margin % | 9.96 | |||||
Net Margin % | 7.95 | |||||
FCF Margin % | 9.5 | |||||
ROE % | 24.51 | |||||
ROA % | 19.69 | |||||
ROIC % | 117.88 | |||||
ROC (Joel Greenblatt) % | 199.83 | |||||
ROCE % | 32.84 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 10.81 | |||||
PE Ratio without NRI | 10.81 | |||||
PS Ratio | 0.87 | |||||
PB Ratio | 2.47 | |||||
Price-to-Tangible-Book | 2.39 | |||||
Price-to-Free-Cash-Flow | 9.05 | |||||
Price-to-Operating-Cash-Flow | 8.78 | |||||
EV-to-EBIT | 5.54 | |||||
EV-to-EBITDA | 5.19 | |||||
EV-to-Revenue | 0.59 | |||||
EV-to-FCF | 5.86 | |||||
Price-to-Graham-Number | 1.06 | |||||
Price-to-Net-Current-Asset-Value | 2.53 | |||||
Price-to-Net-Cash | 4.78 | |||||
Earnings Yield (Greenblatt) % | 18.04 | |||||
FCF Yield % | 10.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
EZZ Life Science Holdings Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | 43.715 | ||
EPS (TTM) (A$) | 0.082 | ||
Beta | 0.47 | ||
Volatility % | 68.71 | ||
14-Day RSI | 63.95 | ||
14-Day ATR (A$) | 0.043256 | ||
20-Day SMA (A$) | 0.83125 | ||
12-1 Month Momentum % | 22.64 | ||
52-Week Range (A$) | 0.45 - 0.915 | ||
Shares Outstanding (Mil) | 44.41 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
EZZ Life Science Holdings Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
EZZ Life Science Holdings Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
EZZ Life Science Holdings Ltd Frequently Asked Questions
What is EZZ Life Science Holdings Ltd(ASX:EZZ)'s stock price today?
When is next earnings date of EZZ Life Science Holdings Ltd(ASX:EZZ)?
Does EZZ Life Science Holdings Ltd(ASX:EZZ) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |